Safety of omalizumab administration in chronic spontaneous urticaria during COVID-19 infection: a case report.

Marisa Paulino; Célia Costa; Elisa Pedro

doi:10.22541/au.159413318.86410521

Essential Site Maintenance: Authorea-powered sites will be updated circa 15:00-17:00 Eastern on Tuesday 5 November.
There should be no interruption to normal services, but please contact us at [email protected] in case you face any issues.

loading page

Safety of omalizumab administration in chronic spontaneous urticaria during COVID-19 infection: a case report.

Marisa Paulino,
Célia Costa,
Elisa Pedro